MOTS-c is typically administered via subcutaneous injection into the abdomen, lateral thigh, or flank, rotating injection sites to prevent tissue accumulation
Twelve peptides that had been placed on the FDAs Category 2 restricted compounding list in 2023 are coming off that list effective April 23, 2026
Always consult with a qualified healthcare provider before making decisions about weight loss treatments
These types of patches are still being studied and are different from regular weight-loss patches sold in stores
Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute
For others, it may be lowering the dose to reduce side effects, cost, or treatment burden